Before a clinical trial can begin, research teams can spend days turning a finalized protocol into trial configurations and EDC forms. myLaminin’s AI Clinical Trial Configuration Agent changes that. It reads the protocol and generates study steps, visit schedules, clinical variables and electronic data capture (EDC) forms in minutes. With more than 90% first-pass accuracy and human-in-the-loop review, researchers spend less time configuring trials and more time advancing rese

Multi-site clinical trials are widely used across North America to improve recruitment and accelerate timelines, but hidden operational risks often undermine success. Site variability, uneven engagement, communication breakdowns, and fragmented technology adoption create systemic inefficiencies that erode data quality and compliance. Without integrated oversight and standardized processes, complexity scales faster than control, increasing trial failure risk.

Poor clinical trial coordination drives costly delays, data integrity risks, and regulatory exposure across multi-site studies in Canada, the US, and globally. Fragmented systems, inconsistent documentation, and weak communication slow approvals, inflate Phase III costs, and erode patient trust. Integrated CTMS/CR/os platforms like myLaminin unify stakeholders, streamline workflows, strengthen compliance, and enable real-time oversight turning coordination into a competitive